openPR Logo
Press release

Companion Animal Drugs Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023

04-25-2018 04:47 PM CET | Health & Medicine

Press release from: Precision Business Insights

Companion Animal Drugs Market

Companion Animal Drugs Market

Global Companion Animal Drugs Market:By Product Type (Antimicrobials, Ectoparasiticides, Endoparacitides, Endectoparaciticides, Anti-inflammatory Drugs, Anti-Obesity Drugs, Behavioral Products, Biologic Drugs and Others), By Animal Type (Feline, Canine, and Equine), By Route of Administration (Oral, Parenteral, Topical, and Others), Distribution Channel (Veterinary Pharmacies, Veterinary Hospitals, Veterinary Clinics, and E-Commerce), and Geography – Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023


Companion Animal Drugs Market Report Description:

The Companion Animal Drugs Market report gives a comprehensive outlook on companion animal drugs market across the globe with special emphasis on key regions such as North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa (MEA). The report on companion animal drugs market gives historical, current, and future market sizes (US$ Mn) on the basis of product type, animal type, route of administration, distribution channel, and geographic regions. This report studies companion animal drugs market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, the companion animal drugs market report includes animal demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed Companion Animal Drugs Market to better equip clients with possible investment opportunities across the regions (Regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the companion animal drugs market report include suppliers, manufacturers, marketers, policymakers, and veterinary healthcare service providers engaged in manufacturing and supply of companion animal drug products.

A sample of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/global-companion-animal-drugs-market/#ulp-4H8Z4LpNMLEuOnnx


Global Companion Animal Drugs Market:

Global companion animal drugs market estimated to be valued US$ XX Mn in 2017 and poised to grow at CAGR of 5.6% over 2017-2023. The market for companion animal drugs projected to reach US$ XX Mn by 2023 owing to rising human and companion animals bondage by means of adoption across the globe.

Rising Pet companionship to the human beings expected to drive the companion animal drugs market over the forecast period

Companion animals have been trusted for their companionship to the human throughout the history and keeping the companion animals healthy is a top priority for caregivers everywhere in the world, which is expected to drive the companion animal market over six years forecast period. Moreover, several studies on human and companion animals’ interactions showed that association with companion animals results in positive health benefits. Therefore, it is essential to veterinarians and caregivers to give utmost attention to companion animal health as companion animals are the primary source of zoonotic diseases spread to humans and vice versa, this is expected to create significant market demand for companion animal drugs over the forecast period.

Increasing per pet expenditure in recent times expected to drive market revenue growth

Several respondents and pet owners revealed that pet expenditure is increasingly becoming an integral part of their monthly expenditure and companion animals are part of several families across the developed and developing economies. Moreover, rising interactions between pets and human beings prompting the caregivers and pet owners to adopt better healthcare services to the companion animals this is projected to drive market revenue growth over the forecast period.

North America accounted for larger market revenue share in global companion animal drugs market

U.S. market dominated the companion animal drugs market with largest market share in North America market with moderate growth rate. Europe companion animal drugs market holds a significant share in the global companion animal drugs market and projected to grow at significant growth over the forecast period.

To view TOC of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/global-companion-animal-drugs-market/#ulp-c654SbFYO64MsOhu


Competition Assessment

Key players profiled in the global Companion Animal Drugs market include:
• Bayer AG (Germany)
• Boehringer Ingelheim GmbH (Germany)
• Ceva Santé Animale (France)
• Eli Lilly and Company (U.S)
• Hester biosciences (India)
• Merck & Co., Inc. (U.S)
• Vétoquinol S.A. (France)
• Virbac S.A. (France)
• Zoetis Inc. (U.S)

Need more information about this report @
https://www.precisionbusinessinsights.com/market-reports/global-companion-animal-drugs-market/#ulp-14mlyhjMGhVjZqa3

Players in the companion animal drugs market are launching the products in the market to garner larger market share. For instance, in July 2016, Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, received U.S. Food and Drug Administration’s approval for BRAVECTO (fluralaner topical solution) a topical treatment for fleas and ticks for both cats and dogs.

Key Findings of the Report:

• Companion animal drugs market expanding at 5.6% CAGR over 2017 to 2023 to reach market value of US$ XX Mn by 2023 owing to increased adoption pet animals and rising zoonotic diseases
• Based on product type parasiticides accounted for larger market revenue share in 2016 and projected gain larger market revenue share over the forecast period
• Veterinary clinics distribution channel is the prime source for companion drugs across the globe and expected to remain attractive over the forecast period
• Players focusing on launching products to retain market position in global companion animal drugs market
Key Features of the Report:

• The report provides granular level information about the market size, regional market share, historic market (2012-2016) and forecast (2017-2023)
• The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
• The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
• The report tracks recent innovations, key developments and startup’s details that are actively working in the market
• The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
• The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
Detailed Segmentation

By Product Type
• Antimicrobials
• Ectoparasiticides
• Endoparacitides
• Endectoparaciticides
• Anti-inflammatory Drugs
• Anti-Obesity Drugs
• Behavioral Products
• Biologic Drugs
• Others

By Animal Type
• Feline
• Canine
• Equine

By Route of Administration
• Oral
• Parenteral
• Topical
• Others
Distribution Channel
• Veterinary Pharmacies
• Veterinary Hospitals
• Veterinary Clinics
• E-Commerce


Get Full Summery @
https://www.precisionbusinessinsights.com/market-reports/global-companion-animal-drugs-market

About Precision Business Insights

Precision Business Insights is one of the leading market research and business consulting firm, the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised which follow a holistic approach to solve needs of market research services based on our client needs.

Precision Business Insights mission is to provide high-quality market research reports and generate key insights to our clients. PBI’s approachable strategies are to help clients to make key decisions for business growth.Precision Business Insights vision is to become most valued partner to fortune 500 companies by providing agile, accurate, and actionable market insights

Contact to Precision Business Insights,
Kemp House,
152 – 160 City Road,
London EC1V 2NX
Email: sales@precisionbusinessinsights.com
Toll Free (US): +1-866-598-1553
Website @ https://www.precisionbusinessinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Companion Animal Drugs Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023 here

News-ID: 1030673 • Views:

More Releases from Precision Business Insights

Biochar Market Growth Is Attributed To The Increased Production Of Biochar Through Pyrolysis Technology
Biochar Market Growth Is Attributed To The Increased Production Of Biochar Throu …
According to Precision Business Insights (PBI), the latest report biochar market was valued at USD 243.8 million in 2022, growing at a 12.6% CAGR during the forecast period 2023 to 2029. The rising demand for organic and eco-friendly products drives the biochar market. Utilizing biochar corresponds with organic farming methods, improving market prospects. Furthermore, biochar is a potential material for water treatment and remediation because of its capacity to absorb
Vapor Recovery Units Market Growth Is Attributed To The Increased Adoption Of Membrane Separation Technology
Vapor Recovery Units Market Growth Is Attributed To The Increased Adoption Of Me …
According to Precision Business Insights (PBI), latest report vapor recovery units market was valued at USD 923.7 million in 2022 and is poised to grow at a CAGR of 4.2% during the forecast period 2023 to 2029. The adoption of stringent environmental regulations by governments and international bodies to reduce air pollution and greenhouse gas emissions in various countries drives the demand for the vapor recovery unit's market. Furthermore, the
Pyrite Market Growth Is Attributed To The Increased Demand In Jewelry Industry
Pyrite Market Growth Is Attributed To The Increased Demand In Jewelry Industry
According to Precision Business Insights (PBI), latest report pyrite market is growing at 4.9% CAGR during the forecast period 2023 to 2029. The increased application of pyrite in the manufacturing of sulfuric acid drives the pyrite market. The increase of prices of gold has led to increased demand for imitation jewelry which is anticipated to propel the pyrite market growth. Furthermore, the demand for sulphuric acid in a variety of
Industrial Boilers Market Growth Is Attributed To The Increased Use In Power Generation
Industrial Boilers Market Growth Is Attributed To The Increased Use In Power Gen …
According to Precision Business Insights (PBI), the latest report industrial boilers market size was valued at USD 15,261.8 million in 2022 and is poised to grow at a 3.1% CAGR during the forecast period 2023 to 2029. The adoption of stringent environmental regulations to maintain emission standards and carbon reduction in several countries drives the industrial boilers market. Furthermore, the advancement in boiler technology, such as better combustion systems, greater

All 5 Releases


More Releases for Drug

Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions. Alcohol abuse and drug
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.  Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and …
This year’s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June. The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drug